3 Comments

IntegenX Raises $15.6M, Buys VC-backed GenVault

Genetic analysis company IntegenX has raised $15.6 million in venture capital, and acquired biotech company GenVault Corp. Life science investor Domain Associates led the round, which included participation from previous investors In-Q-Tel and RONAholdings LLC. GenVault’s existing investors QuestMark Partners, Cross Creek Partners, and Greenspring Associates now join the syndicate backing IntegenX. Pleasanton, Calif.-based IntegenX designs, manufactures and markets automated DNA and RNA based sample preparation.

PEHUB Community

Join the 12493 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

Look Who’s Tweeting

Reuters VC and PE feed

RSS Feed Widget

Groups